Swiss pharmaceutical firm Sintetica creates a healthy working environment
28 sept. 2018 04h30 HE
|
European CEO
LONDON, Sept. 28, 2018 (GLOBE NEWSWIRE) -- The worldwide anaesthesia drugs market is predicted to experience a compound annual growth rate of 3.5 percent between 2018 and 2023, driven by the...
BioDelivery Sciences to Present at the Cantor Fitzgerald Global Healthcare Conference and the Ladenburg Thalmann 2018 Healthcare Conference
25 sept. 2018 08h00 HE
|
BioDelivery Sciences International, Inc.
RALEIGH, N.C., Sept. 25, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial stage specialty pharmaceutical company dedicated to patients...
U.S. Medical Marijuana Market worth over USD 8 billion by 2024: Global Market Insights, Inc.
17 sept. 2018 06h15 HE
|
Global Market Insights, Inc
Sellbyville, Delaware, Sept. 17, 2018 (GLOBE NEWSWIRE) -- The U.S. Medical Marijuana Market is poised to surpass USD 8.0 billion by 2024; according to a new research study published by Global...
BioDelivery Sciences to Host Institutional Investor and Analyst Day on Friday, October 5, 2018
13 sept. 2018 07h30 HE
|
BioDelivery Sciences International, Inc.
RALEIGH, N.C., Sept. 13, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial stage specialty pharmaceutical company dedicated to patients...
BioDelivery Sciences to Present at the 2018 Janney Montgomery Scott Healthcare Conference
10 sept. 2018 08h00 HE
|
BioDelivery Sciences International, Inc.
RALEIGH, N.C., Sept. 10, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ:BDSI), a leading commercial stage specialty pharmaceutical company dedicated to patients living...
Medical Marijuana Market worth over $55 billion by 2024: Global Market Insights, Inc.
22 août 2018 07h00 HE
|
Global Market Insights, Inc
Sellbyville, Delaware, Aug. 22, 2018 (GLOBE NEWSWIRE) -- Global Medical Marijuana Market outlook is projected to surpass USD 55 billion by 2024, says a new Global Market Insights, Inc. report...
BioDelivery Sciences to Present at the Rodman & Renshaw 20th Annual Global Investment Conference
21 août 2018 08h00 HE
|
BioDelivery Sciences International, Inc.
RALEIGH, N.C., Aug. 21, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc., (NASDAQ:BDSI), a leading commercial specialty pharmaceutical company dedicated to patients living with...
BioDelivery Sciences Secures Significant Expanded Preferred Coverage for BELBUCA®
15 août 2018 09h26 HE
|
BioDelivery Sciences International, Inc.
RALEIGH, N.C., Aug. 15, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ:BDSI), a leading commercial specialty pharmaceutical company dedicated to patients living with...
1st Patient Treated for Osteoarthritis Knee Pain in Sorrento Resiniferatoxin Phase 1B Trial Meets Both Safety and Efficacy Expectations
13 août 2018 04h00 HE
|
Sorrento Therapeutics, Inc.
SAN DIEGO, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE, "Sorrento"), announced that the first enrolled patient in the phase 1b study of its non-opioid, afferent nerve...
BioDelivery Sciences Reports Strong Second Quarter 2018 Financial Results
09 août 2018 16h05 HE
|
BioDelivery Sciences International, Inc.
BELBUCA® Continues Its Accelerated Record Prescription Growth of 80% YOY and 31% Versus the Prior Quarter Company Provides Overview of New Plan to Capitalize on Long Term Net Revenue Potential of...